Condition: Eustachian Tube Dysfunction · Sponsor: Cedars-Sinai Medical Center
Intranasal nasal steroid sprays are the mainstay of treatment for chronic Eustachian tube dysfunction despite having little supportive evidence in the literature. A novel, commercially available nasal spray delivery system is available now for fluticasone that improves its delivery to the nasopharynx. The hypothesis of this study is that fluticasone using the novel spray system is effective for Eustachian tube dysfunction (ETD).
This description comes directly from the study's public registry record.
Missael Vasquez · 424-315-2437 · missael.vasquez@cshs.org
Laura Sarmiento, CCRP · 3104234295 · laura.sarmiento@cshs.org
Always discuss trial participation with your own doctor first.
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Sacramento Ear, Nose & Throat | Sacramento, California, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| Ochsner Health System | New Orleans, Louisiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05275686